able semaglutide FBI warns about counterfeit weight loss drugs Semaglutide, also known as Ozempic,

Oral and long-acting formulations could also dramatically expand GLP-1 uptake, further increasing demand

Sekimoto, R

WL: Investigation, Data curation, Formal analysis, Methodology, Software, Validation, Writing original draft

These results rank among the most dramatic weight-loss outcomes ever reported in a late-stage clinical study and signal a paradigm shift in how meaningful benefit is defined across metabolic and related chronic diseases

By selectively activating GLP-1/GIP receptors, it regulates metabolic pathways related to appetite control, glucose metabolism, and energy balance, producing biological effects such as sugar control and weight loss